Department of Gastroentestinal Surgery, Hvidovre Hospital
Hvidovre, DK-2650, Denmark
NCT Number: NCT01579721
Background: Single-port laparoscopic surgery is emerging as a method to improve morbidity and cosmetic benefits of conventional laparoscopic surgery and minimize the surgical trauma. However, the feasibility of this procedure in rectal surgery has not been determined yet. The aim of this study is to evaluate our initial experience using single port access in laparoscopic rectal surgery.
Design: randomized, prospective clinical study Patients: 40 patients
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Hvidovre, DK-2650, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single incision laparoscopic surgery for rectal cancer
Time frame: 30 days
The purpose of this study is to compare 30-days postoperative morbidity between the two groups
Time frame: 72 hours postoperatively
to compare results of blood-samples (C-reactive protein, leucocyte-count and interleukin-6) 72 hours postoperatively between the two groups
Time frame: 5 days postoperatively
to compare postoperative results (postoperative pain, time to bowel function, time to regain full diet and mobilisation) between the two groups.
Time frame: 30 days
Comparison of the oncological results (quality of specimen, completeness of mesorectal fascia, circumferential resection margin, number of harvested lymphnodes, TNM-classification) between the two groups.
Hvidovre University Hospital
Other
Prospective Randomized Study of Single Incision Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Rectal Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04028479
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Idaho Falls, Idaho, United States
View Trial DetailsNCT01206530
Adenocarcinoma, Carcinoma
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04864067
Adenocarcinoma, Carcinoma
Santiago, RM, Chile
View Trial DetailsNCT01111604
Adenocarcinoma, Carcinoma
Cincinnati, Ohio, United States
View Trial Details